Fund Holdings — Sarissa Capital Management LP

Total Portfolio Value:
$177.88M
Total Bought:
$4.11M
Total Sold:
$6.72M
Net Transaction:
-$2.61M
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Innoviva, Inc.(INVA)2,130,9501,890,604-240,346$49.65M$42.94M24.14%-$6.72M
Ironwood Pharmaceuticals, Inc.CL A(IRWD)9,188,6359,188,6350$32.25M$38.68M21.75%+$6.43M
Amarin Corp PlcADR1,673,3951,673,3950$24.20M$26.67M15.00%+$2.48M
Neurocrine Biosciences, Inc.(NBIX)116,533116,5330$15.35M$19.64M11.04%+$4.29M
Cytokinetics, Incorporated(CYTK)228,623228,6230$15.07M$19.48M10.95%+$4.41M
Lantheus Holdings, Inc.(LNTH)166,919166,9190$12.66M$18.52M10.41%+$5.86M
Biohaven Ltd.(BHVN)563,184582,312+19,128$4.76M$8.66M4.87%+$3.90M
Regeneron Pharmaceuticals, Inc.(REGN)4,1904,1900$3.24M$2.61M1.47%-$624.7K
Vor Biopharma Inc.(VOR)25,39925,3990$453.1K$467.6K0.26%+$14.5K
Biogen Inc.(BIIB)0950+950$0$205.3K0.12%+$205.3K
Page 1 of 1
Sarissa Capital Management LP — 13F Holdings — Q2 2026 | TickerTrail